ES352868A1 - Un procedimiento para purificar o concentrar virus para a- nimales. - Google Patents
Un procedimiento para purificar o concentrar virus para a- nimales.Info
- Publication number
- ES352868A1 ES352868A1 ES352868A ES352868A ES352868A1 ES 352868 A1 ES352868 A1 ES 352868A1 ES 352868 A ES352868 A ES 352868A ES 352868 A ES352868 A ES 352868A ES 352868 A1 ES352868 A1 ES 352868A1
- Authority
- ES
- Spain
- Prior art keywords
- virus
- myxovirus
- polyethylene glycol
- suspension
- polyalkylene glycol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 241000700605 Viruses Species 0.000 title abstract 6
- 241001465754 Metazoa Species 0.000 title abstract 2
- 239000012141 concentrate Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 3
- 229920001515 polyalkylene glycol Polymers 0.000 abstract 3
- 239000002202 Polyethylene glycol Substances 0.000 abstract 2
- 229920001223 polyethylene glycol Polymers 0.000 abstract 2
- 239000013049 sediment Substances 0.000 abstract 2
- 239000011780 sodium chloride Substances 0.000 abstract 2
- 239000000725 suspension Substances 0.000 abstract 2
- 241001559185 Mammalian rubulavirus 5 Species 0.000 abstract 1
- 241000725643 Respiratory syncytial virus Species 0.000 abstract 1
- 241000710799 Rubella virus Species 0.000 abstract 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract 1
- 229930006000 Sucrose Natural products 0.000 abstract 1
- 239000007900 aqueous suspension Substances 0.000 abstract 1
- 239000000872 buffer Substances 0.000 abstract 1
- 238000005119 centrifugation Methods 0.000 abstract 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 abstract 1
- 241001493065 dsRNA viruses Species 0.000 abstract 1
- 239000003792 electrolyte Substances 0.000 abstract 1
- 239000008151 electrolyte solution Substances 0.000 abstract 1
- 230000002779 inactivation Effects 0.000 abstract 1
- 230000007935 neutral effect Effects 0.000 abstract 1
- 239000002953 phosphate buffered saline Substances 0.000 abstract 1
- 229940093429 polyethylene glycol 6000 Drugs 0.000 abstract 1
- 230000001376 precipitating effect Effects 0.000 abstract 1
- 238000001556 precipitation Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000005720 sucrose Substances 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16251—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18551—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36211—Rubivirus, e.g. rubella virus
- C12N2770/36234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1797667 | 1967-04-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES352868A1 true ES352868A1 (es) | 1969-09-01 |
Family
ID=10104487
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES352868A Expired ES352868A1 (es) | 1967-04-19 | 1968-04-18 | Un procedimiento para purificar o concentrar virus para a- nimales. |
Country Status (10)
| Country | Link |
|---|---|
| BE (1) | BE713942A (en:Method) |
| CH (1) | CH532123A (en:Method) |
| DE (1) | DE1767220A1 (en:Method) |
| DK (1) | DK122896B (en:Method) |
| ES (1) | ES352868A1 (en:Method) |
| FR (1) | FR1560875A (en:Method) |
| GB (1) | GB1226743A (en:Method) |
| IL (1) | IL29770A (en:Method) |
| NL (1) | NL6805558A (en:Method) |
| YU (1) | YU34714B (en:Method) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7216091A (en:Method) * | 1971-12-03 | 1973-06-05 | ||
| NZ197553A (en) * | 1980-07-01 | 1985-03-20 | Nat Res Dev | Production of antigens specific to r.s.v.;cell lines bearing these antigens and pharmaceutical compositions |
-
1967
- 1967-04-19 GB GB1797667A patent/GB1226743A/en not_active Expired
-
1968
- 1968-04-07 IL IL29770A patent/IL29770A/xx unknown
- 1968-04-11 DE DE19681767220 patent/DE1767220A1/de active Pending
- 1968-04-15 YU YU866/68A patent/YU34714B/xx unknown
- 1968-04-18 ES ES352868A patent/ES352868A1/es not_active Expired
- 1968-04-18 DK DK173168AA patent/DK122896B/da unknown
- 1968-04-19 BE BE713942D patent/BE713942A/xx unknown
- 1968-04-19 FR FR1560875D patent/FR1560875A/fr not_active Expired
- 1968-04-19 NL NL6805558A patent/NL6805558A/xx unknown
- 1968-04-19 CH CH580068A patent/CH532123A/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| YU86668A (en) | 1979-07-10 |
| DK122896B (da) | 1972-04-24 |
| FR1560875A (en:Method) | 1969-03-21 |
| BE713942A (en:Method) | 1968-10-21 |
| DE1767220A1 (de) | 1971-08-19 |
| IL29770A0 (en) | 1968-06-20 |
| IL29770A (en) | 1971-10-20 |
| YU34714B (en) | 1979-12-31 |
| GB1226743A (en:Method) | 1971-03-31 |
| CH532123A (de) | 1972-12-31 |
| NL6805558A (en:Method) | 1968-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20000265A1 (es) | Composiciones que contienen virus y metodos para concentrar preparados de virus | |
| ES417934A1 (es) | Procedimiento para purificar y concentrar una solucion acuo-sa de polisacarido derivada de algas marinas. | |
| AU592727B2 (en) | Purification of pertussis antigens | |
| JPH04502410A (ja) | ウイルスの生産およびワクチン使用のためのウイルスエンベロープタンパク質の精製 | |
| JPH0559096B2 (en:Method) | ||
| ES352868A1 (es) | Un procedimiento para purificar o concentrar virus para a- nimales. | |
| JPS5359254A (en) | Method of purifying waste liquid produced from photographic treatment using sulfur bacteria and method of recoveryof silver from waste liquid of photographic treatment | |
| JPS57203017A (en) | Purifying method of immunoglobulin | |
| CA1126155A (en) | Immunogenic cell envelope preparations | |
| ES350690A1 (es) | Un metodo para la concentracion y purificacion de los virusdel grupo de la influenza. | |
| JPH06279317A (ja) | Ａ型肝炎（ｈａｖ）の抗原およびワクチンの製造方法 | |
| ES298272A1 (es) | Procedimiento para la obtención de una nueva proteína | |
| US3259546A (en) | Treatment of viruses | |
| RU95117445A (ru) | Способ получения живой гриппозной вакцины | |
| GB1436466A (en) | Method of treating drinks using powdered polyamide adsorbents | |
| CN109134622A (zh) | 口蹄疫病毒抗原的多步连续集成纯化方法 | |
| EP0090660A3 (en) | Neisseria gonorrhoeae vaccine | |
| US3629470A (en) | Process for purification of animal rna viruses | |
| JPS5731623A (en) | Production of gamma-globulin for intravenous injection | |
| FR2181704A1 (en) | Arbo-virus infections vaccines - contg 10-22c unsatd fatty acids or salts pref of petroselinic acid | |
| SU1532050A1 (ru) | Способ очистки суспензии вируса от клеточной ДНК | |
| GB1140316A (en) | Influenza virus sub-unit vaccine | |
| JPS56128795A (en) | Purification of glychrrhizin | |
| RU97109525A (ru) | Препарат "локферон" для лечения и профилактики вирусных заболеваний и способ его получения | |
| Deig et al. | Plaque assay procedure for Colorado tick fever virus |